TFX (Teleflex) Payments of Debt: $-129 Mil (TTM As of Mar. 2026)


TFX Teleflex Inc TFX
76 GF Score
Price $133.54
GF Value $181.32
Valuation Modestly Undervalued
! 7 Warning Signs
View Full Analysis

What is Teleflex Payments of Debt?

Teleflex TFX -0.58% 76 Payments of Debt is $-129 Mil as of Mar. 2026. GuruFocus rates TFX with a GF Score™ of 76/100 and a GF Value™ of $181.32 (Modestly Undervalued). The stock has 7 warning signs investors should review.

Teleflex's Payments of Debt for the three months ended in Mar. 2026 was $-25 Mil.

Teleflex's Payments of Debt for the trailing twelve months (TTM) ended in Mar. 2026 was $-129 Mil.

Teleflex Payments of Debt Related Terms

Teleflex Payments of Debt Historical Data

* Premium members only.

The historical data trend for Teleflex's Payments of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Teleflex Payments of Debt Chart

Teleflex Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Payments of Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1,034.50 -884.50 -544.75 -291.50 -153.00

Teleflex Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Payments of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -49.13 -9.05 -68.54 -26.29 -25.25
TFX
76GF Score
Teleflex Inc TFX
Payments of Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Teleflex Payments of Debt Calculation

Payments of Debt represents all the cash outflow from debt, including both long-term debt and short-term debt.

Payments of Debt for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-129 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Payments of Debt →
What does a Payments of Debt of $-129 Mil mean?
Teleflex (TFX) has a Payments of Debt of $-129 Mil as of Mar. 2026. Payments of Debt is all the cash outflow from debt, including both long-term debt and short-term debt. View historical data on Teleflex and its competitors.
Is Teleflex's Payments of Debt too high?
Teleflex's current Payments of Debt is $-129 Mil. Overall, Teleflex has a GF Score™ of 76/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Teleflex's Payments of Debt compare to STVN and AVTR?
Teleflex's Payments of Debt of $-129 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Payments of Debt for a Medical Devices & Instruments company?
A good Payments of Debt depends on the Medical Devices & Instruments industry context. However, Payments of Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Payments of Debt mean?
A high Payments of Debt can signal that a stock is expensive relative to its fundamentals. Payments of Debt is all the cash outflow from debt, including both long-term debt and short-term debt. View historical data on Teleflex and its competitors. Teleflex's current Payments of Debt is $-129 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Teleflex stock overvalued right now?
Based on GuruFocus' analysis, Teleflex (TFX) is currently considered Modestly Undervalued. The stock's GF Value™ is $181.32, compared to a current price of $133.54 — trading 26.4% below its estimated fair value. The current Payments of Debt is $-129 Mil. Teleflex's overall GF Score™ is 76/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Payments of Debt calculated?
Payments of Debt is calculated from a company's financial statements. For Teleflex (TFX), the current Payments of Debt is $-129 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Teleflex (TFX) Overvalued in 2026?

Based on GuruFocus' analysis, Teleflex stock appears to be undervalued. The current stock price of $133.54 is trading 26.4% below its estimated GF Value™ of $181.32. GuruFocus considers Teleflex to be Modestly Undervalued.

Key valuation signals for TFX:

  • Payments of Debt: $-129 Mil
  • GF Value™: $181.32 vs. price of $133.54 (26.4% below fair value)
  • GF Score™: 76/100 with 7 warning signs

No single metric tells the full story. See the TFX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Teleflex Business Description

Other Exchanges 1TFX:ItalyTBH:Germany
Address 550 East Swedesford Road, Suite 400, Wayne, PA, USA, 19087
Teleflex Inc is a provider of medical technology products focused on enhancing clinical benefits, improving patient and provider safety and reducing total procedural costs. It designs, develops, manufactures and supply medical devices used by hospitals and healthcare providers supporting high-acuity emergent procedures. The company has three reportable segments: Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). It derives maximum revenue from Americas. Its products includes: Anaesthesia, Emergency Medicine, Interventional Cardiology/Radiology, Interventional Urology - UroLift System, Surgery, Urology, and Vascular Access.
76GF Score

Get the complete analysis for TFX

Payments of Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$133.54
Price
$181.32
GF Value